Caseware UK (AP4) 2024.0.164 2024.0.164 2024-08-312024-08-312025-05-2922023-09-01falsetrueNo description of principal activity2The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 11499363 2023-09-01 2024-08-31 11499363 2022-09-01 2023-08-31 11499363 2024-08-31 11499363 2023-08-31 11499363 c:Director1 2023-09-01 2024-08-31 11499363 d:CurrentFinancialInstruments 2024-08-31 11499363 d:CurrentFinancialInstruments 2023-08-31 11499363 c:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 11499363 c:FullAccounts 2023-09-01 2024-08-31 11499363 c:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 11499363 c:Micro-entities 2023-09-01 2024-08-31 11499363 e:PoundSterling 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure

Registered number: 11499363









JP NEWMAN MEDICAL LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2024

 
JP NEWMAN MEDICAL LTD
REGISTERED NUMBER: 11499363

STATEMENT OF FINANCIAL POSITION
AS AT 31 AUGUST 2024

2024
2023
£
£


Current assets
41,247
31,622

Creditors: amounts falling due within one year
(10,132)
(9,095)

Net current assets
 
 
31,115
 
 
22,527

Total assets less current liabilities
31,115
22,527


Net assets
31,115
22,527



Capital and reserves
31,115
22,527


Page 1

 
JP NEWMAN MEDICAL LTD
REGISTERED NUMBER: 11499363
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 AUGUST 2024

Notes


General information

JP Newman Medical Ltd is a private company limited by shares and registered in England & Wales. The address of its registered office is 6 The Drive, Radlett, WD7 7DA.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


Directors' benefits: advances, credits and guarantees

At the reporting date J Newman, a director, owed the company £29,413 (2023: £8,577 owed to J Newman). The loan was repaid within 9 months after the year end.


Directors' confirmations

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 May 2025.


J Newman
Director

 
Page 2